COVID-19 Vaccines | Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021

COVID-19 Vaccines | Biological E to begin producing 75-80 million doses of vaccine candidate from August 2021 The company is also starting Phase III trials of its recombinant protein vaccine candidate from August.

No comments:

Post a Comment